Review article
Galectin-3, a prognostic marker – and a therapeutic target?
Galectina-3: indicador de prognóstico. Alvo de intervenção terapêutica?
Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal
Read
8925
Timeswas read the article
2217
Total PDF
6708
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 10 | 2 | 12 |
| 2025 5 | 62 | 16 | 78 |
| 2025 4 | 58 | 24 | 82 |
| 2025 3 | 56 | 23 | 79 |
| 2025 2 | 39 | 17 | 56 |
| 2025 1 | 34 | 24 | 58 |
| 2024 12 | 24 | 22 | 46 |
| 2024 11 | 59 | 38 | 97 |
| 2024 10 | 45 | 28 | 73 |
| 2024 9 | 51 | 21 | 72 |
| 2024 8 | 35 | 23 | 58 |
| 2024 7 | 38 | 28 | 66 |
| 2024 6 | 24 | 24 | 48 |
| 2024 5 | 35 | 30 | 65 |
| 2024 4 | 38 | 21 | 59 |
| 2024 3 | 30 | 13 | 43 |
| 2024 2 | 26 | 17 | 43 |
| 2024 1 | 31 | 26 | 57 |
| 2023 12 | 26 | 18 | 44 |
| 2023 11 | 36 | 19 | 55 |
| 2023 10 | 26 | 33 | 59 |
| 2023 9 | 26 | 17 | 43 |
| 2023 8 | 20 | 17 | 37 |
| 2023 7 | 24 | 10 | 34 |
| 2023 6 | 30 | 9 | 39 |
| 2023 5 | 34 | 24 | 58 |
| 2023 4 | 25 | 3 | 28 |
| 2023 3 | 39 | 25 | 64 |
| 2023 2 | 24 | 14 | 38 |
| 2023 1 | 36 | 15 | 51 |
| 2022 12 | 28 | 15 | 43 |
| 2022 11 | 33 | 20 | 53 |
| 2022 10 | 29 | 21 | 50 |
| 2022 9 | 33 | 24 | 57 |
| 2022 8 | 61 | 48 | 109 |
| 2022 7 | 37 | 33 | 70 |
| 2022 6 | 37 | 19 | 56 |
| 2022 5 | 39 | 29 | 68 |
| 2022 4 | 33 | 23 | 56 |
| 2022 3 | 33 | 41 | 74 |
| 2022 2 | 48 | 34 | 82 |
| 2022 1 | 70 | 26 | 96 |
| 2021 12 | 35 | 26 | 61 |
| 2021 11 | 35 | 34 | 69 |
| 2021 10 | 38 | 25 | 63 |
| 2021 9 | 30 | 24 | 54 |
| 2021 8 | 51 | 29 | 80 |
| 2021 7 | 39 | 27 | 66 |
| 2021 6 | 37 | 19 | 56 |
| 2021 5 | 34 | 30 | 64 |
| 2021 4 | 88 | 63 | 151 |
| 2021 3 | 67 | 15 | 82 |
| 2021 2 | 67 | 12 | 79 |
| 2021 1 | 27 | 12 | 39 |
| 2020 12 | 51 | 7 | 58 |
| 2020 11 | 49 | 15 | 64 |
| 2020 10 | 91 | 22 | 113 |
| 2020 9 | 83 | 11 | 94 |
| 2020 8 | 29 | 10 | 39 |
| 2020 7 | 50 | 3 | 53 |
| 2020 6 | 62 | 14 | 76 |
| 2020 5 | 70 | 5 | 75 |
| 2020 4 | 54 | 14 | 68 |
| 2020 3 | 66 | 16 | 82 |
| 2020 2 | 168 | 23 | 191 |
| 2020 1 | 53 | 9 | 62 |
| 2019 12 | 42 | 3 | 45 |
| 2019 11 | 43 | 8 | 51 |
| 2019 10 | 23 | 12 | 35 |
| 2019 9 | 55 | 8 | 63 |
| 2019 8 | 35 | 5 | 40 |
| 2019 7 | 46 | 11 | 57 |
| 2019 6 | 43 | 11 | 54 |
| 2019 5 | 53 | 12 | 65 |
| 2019 4 | 79 | 19 | 98 |
| 2019 3 | 77 | 17 | 94 |
| 2019 2 | 71 | 15 | 86 |
| 2019 1 | 62 | 2 | 64 |
| 2018 12 | 69 | 17 | 86 |
| 2018 11 | 117 | 7 | 124 |
| 2018 10 | 126 | 17 | 143 |
| 2018 9 | 41 | 13 | 54 |
| 2018 8 | 64 | 11 | 75 |
| 2018 7 | 36 | 2 | 38 |
| 2018 6 | 46 | 7 | 53 |
| 2018 5 | 46 | 10 | 56 |
| 2018 4 | 44 | 10 | 54 |
| 2018 3 | 44 | 6 | 50 |
| 2018 2 | 44 | 5 | 49 |
| 2018 1 | 30 | 5 | 35 |
| 2017 12 | 61 | 9 | 70 |
| 2017 11 | 53 | 7 | 60 |
| 2017 10 | 48 | 13 | 61 |
| 2017 9 | 63 | 6 | 69 |
| 2017 8 | 55 | 15 | 70 |
| 2017 7 | 74 | 8 | 82 |
| 2017 6 | 48 | 12 | 60 |
| 2017 5 | 112 | 22 | 134 |
| 2017 4 | 55 | 6 | 61 |
| 2017 3 | 63 | 5 | 68 |
| 2017 2 | 69 | 4 | 73 |
| 2017 1 | 78 | 9 | 87 |
| 2016 12 | 66 | 13 | 79 |
| 2016 11 | 65 | 13 | 78 |
| 2016 10 | 72 | 10 | 82 |
| 2016 9 | 88 | 9 | 97 |
| 2016 8 | 16 | 1 | 17 |
| 2016 7 | 23 | 15 | 38 |
| 2016 6 | 23 | 15 | 38 |
| 2016 5 | 26 | 13 | 39 |
| 2016 4 | 87 | 2 | 89 |
| 2016 3 | 107 | 30 | 137 |
| 2016 2 | 110 | 42 | 152 |
| 2016 1 | 108 | 41 | 149 |
| 2015 12 | 103 | 33 | 136 |
| 2015 11 | 89 | 23 | 112 |
| 2015 10 | 82 | 29 | 111 |
| 2015 9 | 69 | 24 | 93 |
| 2015 8 | 72 | 25 | 97 |
| 2015 7 | 78 | 18 | 96 |
| 2015 6 | 116 | 15 | 131 |
| 2015 5 | 83 | 35 | 118 |
| 2015 4 | 214 | 63 | 277 |
Show all
